Home » Author Archive

Marqeta (NASDAQ:MQ) Releases Quarterly Earnings Results, Misses Estimates By $0.01 EPS

Posted by Matthew Jenks on Nov 5th, 2024

Marqeta (NASDAQ:MQ – Get Free Report) announced its quarterly earnings data on Monday. The company reported ($0.06) earnings per share for the quarter, missing the consensus estimate of ($0.05) by ($0.01), Briefing.com reports.... More of this article »

Novanta (NASDAQ:NOVT) Releases Q4 Earnings Guidance

Posted by Matthew Jenks on Nov 5th, 2024

Novanta (NASDAQ:NOVT – Get Free Report) updated its fourth quarter earnings guidance on Tuesday. The company provided earnings per share guidance of $0.70-0.74 for the period, compared to the consensus earnings per share estimate... More of this article »

Skechers U.S.A. (NYSE:SKX) Lowered to Hold Rating by StockNews.com

Posted by Matthew Jenks on Nov 5th, 2024

StockNews.com downgraded shares of Skechers U.S.A. (NYSE:SKX – Free Report) from a buy rating to a hold rating in a report issued on Monday morning. A number of other equities analysts have also recently commented on SKX. Morgan... More of this article »

Central Bank & Trust Co. Boosts Holdings in Novo Nordisk A/S (NYSE:NVO)

Posted by Matthew Jenks on Nov 5th, 2024

Central Bank & Trust Co. increased its stake in Novo Nordisk A/S (NYSE:NVO – Free Report) by 6,299.6% in the 3rd quarter, according to the company in its most recent disclosure with the SEC. The institutional investor ... More of this article »

Stoneridge Investment Partners LLC Makes New Investment in Treace Medical Concepts, Inc. (NASDAQ:TMCI)

Posted by Matthew Jenks on Nov 5th, 2024

Stoneridge Investment Partners LLC purchased a new stake in Treace Medical Concepts, Inc. (NASDAQ:TMCI – Free Report) in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The fund purchased... More of this article »